melanocortin receptor agonist
Bremelanotide dose
Answer
FDA label for Vyleesi: The recommended dosage of VYLEESI is 1.75 mg administered subcutaneously in the abdomen or thigh, as needed, at least 45 minutes before anticipated sexual activity.
Not dosing advice.
FDA LABEL
What the approved labels state
Vyleesi NDA210557 · label of 2025-11-13 Regulator
The recommended dosage of VYLEESI is 1.75 mg administered subcutaneously in the abdomen or thigh, as needed, at least 45 minutes before anticipated sexual activity.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.